Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This report describes a clinical case of a 38-year-old man diagnosed with Birt-Hogg-Dubé syndrome, confirmed by genetic testing, highlighting the presentation of multiple renal tumors and bilateral lung cysts.

This study found that early-onset androgenetic alopecia in men was associated with a higher prevalence of metabolic syndrome and carotid arteriosclerosis compared to controls.

This study found that men with early-onset androgenetic alopecia who also met criteria for the male PCOS-equivalent may have impaired gonadal steroidogenesis, suggesting increased risk of future gonadal dysfunction.

This study used a new multimolecular spectral method to uncover structural differences in hair keratin from individuals with androgenetic alopecia compared to healthy individuals, identifying potential biomarkers and providing insights for developing new treatments.

This study reported that androgenetic alopecia affects the psychosocial aspects and quality of life differently depending on marital status and occupational category, with married patients and professional workers experiencing higher emotional impact.

This study in a Korean population identified two novel genetic variants that may increase the risk of androgenetic alopecia, contributing to understanding its genetic basis in non-European populations.

This review discusses recent advances in understanding the molecular mechanisms of androgenic alopecia and developments in its pharmacotherapy, with a focus on factors influencing hair follicle regeneration in genetically predisposed individuals.

This pilot study found that a novel regimen including NuH Hair led to significant hair growth in male patients with androgenic alopecia, regardless of atopy status, with quicker results when additional treatment components were used.

DMG-Na may help reduce hair loss and improve hair growth, but more research is needed.

Women with androgenetic alopecia may have higher blood pressure levels.

This article discusses the psychosocial impact of androgenetic alopecia and does not report new findings; it highlights the perceived effects of hair loss on self-esteem and confidence.

This review examines current literature on botulinum toxin type A for androgenetic alopecia, reporting an association with increased hair growth and improved hair density, though further research is needed.

This study investigated the factors affecting androgenetic alopecia and found no significant correlation between androgenetic alopecia and ischemia-modified albumin levels in young male subjects.

This review examines the effectiveness of current treatments for androgenetic alopecia, offering plastic surgeons evidence-based guidance for choosing safe and effective options, but reports no new results.

This review concluded that Unani medicine offers a promising holistic approach to managing androgenetic alopecia by focusing on humoral balance and follicular rejuvenation, but further scientific validation is needed for widespread clinical use.

This review discusses current treatment options for androgenetic alopecia, noting that most lack robust evidence for efficacy and safety, highlighting the need for more comprehensive studies.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

In this study of androgenetic alopecia, therapeutic effectiveness improved with increased severity and treatment duration, and combined therapy was more effective than either oral or topical treatment alone.

This study, conducted among Egyptians, found a borderline significant association between the Stul polymorphism of the androgen receptor gene and androgenetic alopecia in males, with higher androgen receptor expression in balding scalp areas.

This study found a significant association between early onset androgenetic alopecia and metabolic syndrome, with higher prevalence of metabolic risk factors in affected individuals compared to a control group.

This article discusses male androgenetic alopecia, describing its progression and pattern, and reports no new findings or clinical results.

UVA exposure worsens hair loss by activating a specific cell pathway.

This study observed no significant association between early-onset androgenetic alopecia and medical comorbidities in the Korean population.

This study found that patients with androgenetic alopecia had significantly higher COVID-19 severity compared to matched controls, suggesting a potential link between androgen pathways and disease severity. The authors suggest further research to validate this hypothesis and explore antiandrogen treatments for managing COVID-19 severity.

In this study, researchers observed a significant association between female androgenetic alopecia and coronary artery disease in women under 55, supporting a link similar to that seen in men.

This study found that water fractions of Angiopteris evecta stimulated hair growth in male rabbits, suggesting potential alopecia treatment benefits pending further research in humans.

In this study, the researchers explored how the loss of structural integrity in hair follicles due to reduced α-SMA expression in the vertex area may contribute to androgenetic alopecia.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

In this randomized controlled trial, the topical application of a PGA solution significantly increased hair density in patients with androgenetic alopecia compared to placebo, with no adverse reactions reported over 24 weeks, suggesting its potential as a safe and effective treatment option.

This study found a significant association between the severity of male pattern baldness and increased levels of depression, loneliness, and internet addiction among male medical students with androgenetic alopecia.